跳至主要内容
临床试验/NCT01427127
NCT01427127Unknown4 期

Effect of Ramosetron on Bowel Motility and PONV After Laparoscopic Stomach and Colorectal Resection

Kyunghee University Medical Center1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2010年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
64
试验地点
1
主要终点
time from surgery to passage of gas

研究概览

简要总结

Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment diarrhea-predominant irritable bowel syndrome. The investigators examine the effect of ramosetron used for preventing postoperative nausea and vomiting on bowel motility.

详细描述

Ramosetron, a new potent and long-acting selective 5-HT3 receptor antagonist, is effective for preventing postoperative nausea and vomiting. Also several studies reported that ramosetron is effective treatment of irritable bowel syndrome because it inhibits the accelerated colonic transit, abnormal colonic water transport, defecation abnormality, and the lowered colonic perceptual threshold by corticotrophin-releasing hormone. There is no study about the effect of ramosetron used for preventing postoperative nausea and vomiting on postoperative bowel motility. In this study, the investigators examine the effect of ramosetron on postoperative bowel motility.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 20-70 yr of age,
  • ASA I or II,
  • scheduled for laparoscopic colorectal surgery

排除标准

  • antiemetic use within 24hr prior to surgery
  • steroid use within 24hr prior to surgery or 48hr after surgery
  • insulin dependent DM
  • cardiovascular or pulmonary disease
  • renal or hepatic insufficiency
  • BMI >=35kg/m2
  • pregnancy

研究组 & 干预措施

ramosetron

Experimental

Patients received intravenous ramosetron 0.3 mg at the end of surgery and 24hr after surgery.

干预措施: Ramosetron (Drug)

Normal saline

Placebo Comparator

Patients received intravenous normal saline at end of surgery and 24hr after surgery.

干预措施: Ramosetron (Drug)

结局指标

主要结局

time from surgery to passage of gas

时间窗: within 10days after surgery

time from surgery to defecation

时间窗: within 10 days after surgery

次要结局

  • incidence and severity of postoperative nausea and vomiting(0 - 6 hours, 6-24 hours, and 24-48 hours after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mi Kyeong Kim

Assistant Professor

Kyunghee University Medical Center

研究点 (1)

Loading locations...

相似试验